Find Edaravone manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 89-25-8, 3-methyl-1-phenyl-2-pyrazolin-5-one, Radicut, Norphenazone, Mci-186, Developer z
Molecular Formula
C10H10N2O
Molecular Weight
174.20  g/mol
InChI Key
QELUYTUMUWHWMC-UHFFFAOYSA-N

Edaravone
An antipyrine derivative that functions as a free radical scavenger and neuroprotective agent. It is used in the treatment of AMYOTROPHIC LATERAL SCLEROSIS and STROKE.
1 2D Structure

Edaravone

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-methyl-2-phenyl-4H-pyrazol-3-one
2.1.2 InChI
InChI=1S/C10H10N2O/c1-8-7-10(13)12(11-8)9-5-3-2-4-6-9/h2-6H,7H2,1H3
2.1.3 InChI Key
QELUYTUMUWHWMC-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=NN(C(=O)C1)C2=CC=CC=C2
2.2 Synonyms
2.2.1 MeSH Synonyms

1. 1 Phenyl 3 Methyl 5 Pyrazolone

2. 1-phenyl-3-methyl-5-pyrazolone

3. 3 Methyl 1 Phenyl 2 Pyrazolin 5 One

4. 3-methyl-1-phenyl-2-pyrazolin-5-one

5. Edarabone

6. Mci 186

7. Mci-186

8. Mci186

9. Norantipyrine

10. Norphenazone

11. Phenylmethylpyrazolone

12. Radicava

2.2.2 Depositor-Supplied Synonyms

1. 89-25-8

2. 3-methyl-1-phenyl-2-pyrazolin-5-one

3. Radicut

4. Norphenazone

5. Mci-186

6. Developer Z

7. Methylphenylpyrazolone

8. Norantipyrine

9. C.i. Developer 1

10. Phenyl Methyl Pyrazolone

11. Phenylmethylpyrazolone

12. Radicava

13. 3-methyl-1-phenyl-1h-pyrazol-5(4h)-one

14. 5-methyl-2-phenyl-2,4-dihydro-3h-pyrazol-3-one

15. 1-phenyl-3-methyl-5-oxo-2-pyrazoline

16. 5-methyl-2-phenyl-4h-pyrazol-3-one

17. 1-phenyl-3-methylpyrazolone

18. 3h-pyrazol-3-one, 2,4-dihydro-5-methyl-2-phenyl-

19. 1-phenyl-3-methylpyrazolone-5

20. 3-methyl-1-phenylpyrazol-5-one

21. 3-methyl-1-phenyl-2-pyrazoline-5-one

22. Nci-c03952

23. 2-pyrazolin-5-one, 3-methyl-1-phenyl-

24. 5-pyrazolone, 3-methyl-1-phenyl-

25. 2,4-dihydro-5-methyl-2-phenyl-3h-pyrazol-3-one

26. Edaravone (mci-186)

27. 1-fenyl-3-methyl-2-pyrazolin-5-on

28. 3-methyl-1-phenyl-4,5-dihydro-1h-pyrazol-5-one

29. Chebi:31530

30. Nsc-2629

31. Nsc-26139

32. Antipyrine Related Compound A

33. Mls000069602

34. 3-methyl-1-phenyl-2-pyrazolin-5-one (mci-186)

35. Ci Developer 1

36. Ncgc00164015-01

37. Smr000059020

38. Dsstox_cid_1130

39. Dsstox_rid_75961

40. Dsstox_gsid_21130

41. Monopyrazolone

42. Wln: T5nmv Dhj Br& E1

43. Cas-89-25-8

44. Ccris 512

45. Radicut (tn)

46. Hsdb 4102

47. 3h-pyrazol-3-one,4-dihydro-5-methyl-2-phenyl-

48. Sr-01000000135

49. 1-fenyl-3-methyl-2-pyrazolin-5-on [czech]

50. Einecs 201-891-0

51. Mfcd00003138

52. Unii-s798v6yjrp

53. Brn 0609575

54. Ai3-03557

55. Mci186

56. (edaravone)

57. Radicava (tn)

58. (mci-186)

59. Cds1_000986

60. Spectrum_000267

61. Tocris-0786

62. Mci-186; Edaravone

63. Edaravone [usan:inn]

64. Maybridge1_005738

65. Opera_id_1057

66. Spectrum2_001574

67. Spectrum3_000971

68. Spectrum4_001091

69. Spectrum5_001217

70. M0687

71. Ec 201-891-0

72. Schembl4704

73. Bspbio_001235

74. Bspbio_002601

75. Kbiogr_000575

76. Kbiogr_001502

77. Kbioss_000575

78. Kbioss_000747

79. Ae-641/00371017

80. Mls001146878

81. Mls002415675

82. Mls006011753

83. Divk1c_001018

84. Divk1c_002026

85. Spectrum1503635

86. Spbio_001508

87. Chembl290916

88. Edaravone (usan/jp17/inn)

89. Dtxsid9021130

90. Bcbcmap01_000127

91. Gtpl11994

92. Hms503k17

93. Hms557m18

94. Kbio1_001018

95. Kbio2_000575

96. Kbio2_000747

97. Kbio2_003143

98. Kbio2_003315

99. Kbio2_005711

100. Kbio2_005883

101. Kbio3_001029

102. Kbio3_001030

103. Kbio3_001821

104. Nsc2629

105. Ninds_001018

106. Bcpp000246

107. Bio1_000438

108. Bio1_000927

109. Bio1_001416

110. Bio2_000448

111. Bio2_000928

112. Hms1362m17

113. Hms1792m17

114. Hms1990m17

115. Hms2234m19

116. Hms3266f04

117. Hms3403m17

118. Hms3411l05

119. Hms3654l15

120. Hms3675l05

121. Hms3884a11

122. Pharmakon1600-01503635

123. Act07289

124. Bcp26336

125. Hy-b0099

126. Nsc26139

127. Tox21_112077

128. Tox21_201747

129. Tox21_302819

130. Bdbm50200541

131. Ccg-39352

132. Nsc758622

133. S1326

134. Stk201315

135. Zinc18203737

136. 3-methyl-1-phenyl-2-pyrazolin-5one

137. Akos000313817

138. Tox21_112077_1

139. Ac-4745

140. Bcp9000635

141. Cs-1832

142. Db12243

143. Nsc-758622

144. Sb19128

145. Idi1_001018

146. Idi1_002203

147. 1-pehnyl-3-methyl-5-pyrazalone

148. Ncgc00018218-01

149. Ncgc00018218-02

150. Ncgc00018218-03

151. Ncgc00018218-04

152. Ncgc00018218-05

153. Ncgc00018218-06

154. Ncgc00018218-07

155. Ncgc00018218-08

156. Ncgc00018218-10

157. Ncgc00018218-17

158. Ncgc00022665-02

159. Ncgc00022665-04

160. Ncgc00022665-05

161. Ncgc00022665-06

162. Ncgc00256515-01

163. Ncgc00259296-01

164. Sbi-0051836.p002

165. Db-002517

166. Am20060748

167. Ft-0608243

168. Sw148216-2

169. 5-methyl-2-phenyl-2,4-dihydro-3-pyrazolone

170. 3-methyl-1-phenyl-2-pyrazoline-5-one, 99%

171. 4e-901

172. 5-methyl-2-phenyl-2,4-dihydro-pyrazol-3-one

173. D01552

174. D86209

175. 3-?methyl-?1-?phenyl-?2-?pyrazolin-?5-?one

176. Ab00375776_14

177. Ab00375776_15

178. 2 4-dihydro-5-methyl-2-phenyl-3h-pyrazol-3-one

179. 2,4-dihydro-2-phenyl-5-methyl-3h-pyrazol-3-one

180. A843105

181. Q335099

182. Q-200386

183. Sr-01000000135-2

184. Sr-01000000135-3

185. Sr-01000000135-5

186. 5-methyl-2-phenyl-2,4-dihydro-3h-pyrazol-3-one #

187. Brd-k35458079-001-04-2

188. Brd-k35458079-001-12-5

189. Brd-k35458079-001-23-2

190. Z50145861

191. F0391-0021

192. 3-methyl-1-phenyl-2-pyrazoline-5-one, Saj Special Grade

193. 3-methyl-1-phenyl-2-pyrazoline-5-one, Purum, >=98.0% (nt)

194. 5-methyl-2-phenyl-2,4-dihydro-3h-pyrazol-3-one (edaravone)

195. Phenazone Impurity A, European Pharmacopoeia (ep) Reference Standard

196. 5-methyl-2-phenyl-1,2-dihydropyrazol-3-one;3-methyl-1-phenyl-2-pyrazolin-5-one

197. Antipyrine Related Compound A, United States Pharmacopeia (usp) Reference Standard

2.3 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 174.20 g/mol
Molecular Formula C10H10N2O
XLogP31.3
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count2
Rotatable Bond Count1
Exact Mass174.079312947 g/mol
Monoisotopic Mass174.079312947 g/mol
Topological Polar Surface Area32.7 Ų
Heavy Atom Count13
Formal Charge0
Complexity241
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Indicated for improving neurological symptoms and damage from acute ischemic stroke and delaying disease progression of ALS.


FDA Label


Treatment of amyotrophic lateral sclerosis


Treatment of amyotrophic lateral sclerosis


5 Pharmacology and Biochemistry
5.1 Pharmacology

Edaravone scavenges free hydroxyl radicals and peroxynitrite radicals which are highly associated with neuronal damage/death from many cerebral vascular disorders such as ischemic strokes and degenerative neurological disorders such as ALS. It exerts a neuroprotective and antioxidant effect and delays disease progression by limiting the extent of lipid peroxidation via free radical generation and cell membrane damage from oxidative stress. It reversed the reduction in regional blood flow and cerebral edema in a case of ischemic stroke.


5.2 MeSH Pharmacological Classification

Free Radical Scavengers

Substances that eliminate free radicals. Among other effects, they protect PANCREATIC ISLETS against damage by CYTOKINES and prevent myocardial and pulmonary REPERFUSION INJURY. (See all compounds classified as Free Radical Scavengers.)


Neuroprotective Agents

Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)


5.3 ATC Code

N - Nervous system

N07 - Other nervous system drugs

N07X - Other nervous system drugs

N07XX - Other nervous system drugs

N07XX14 - Edaravone


5.4 Absorption, Distribution and Excretion

Absorption

The peak plasma concentration of the parent drug is reached at the end of infusion, without accumulation of the drug with multiple dosing regimen. The mean Cmax value in healthy male adults is 888ng/mL for intravenous infusion. The values of AUC and Cmax are increased in a dose-proportional relationship. The oral bioavailability in mouse studies is 38% of the I.V. delivery.


Route of Elimination

About 0.7-0.9% of the dose is excreted as unchanged drug and 71.0-79.9% of the dose is excreted as metabolites (mostly as glucuronide conjugates) through mainly renal elimination.


Volume of Distribution

The mean Vd value following an intravenous infusion of a single 30mg dose is 18.5L/kg.


Clearance

The mean total plasma drug clearance following an intravenous infusion of a single 30mg dose is 0.1L/min.


5.5 Metabolism/Metabolites

Multiple renal and hepatic uridine diphosphate glucuronosyltransferase (UGT) isoforms catalyze glucuronidation reaction of edaravone to form glucuronide conjugates. Edaravone is also metabolized into sulfate conjugates via sulfotransferase activity, which is the main metabolite form predominantly found circulating in plasma. It is predicted that the sulfate conjugate is hydrolyzed back to edaravone, which is then converted to the glucuronide conjugate in the human kidney before excretion into the urine. These metabolites have no pharmacological activity.


5.6 Biological Half-Life

The mean terminal elimination half-life of edaravone is 4.5 to 6 hours and the half-lives of its metabolites are 2 to 2.8 hours.


5.7 Mechanism of Action

Nootropic and neuroprotective effects are mediated through inhibiting lipid peroxidation and scavenging free radicals. Edaravone acts to increase prostacyclin production, decrease lipoxygenase metabolism of arachidonic acid by trapping hydroxyl radicals, and inhibit alloxan-induced lipid peroxidation and quench active oxygen species. It targets various kinds of cells, including neurons, endothelial cells and myocardial cells. There is also evidence of reduction of neuronal nitric oxide synthase (nNOS) levels and potentiation of SOD1 levels after transient ischemia in rabbits thus preventing spinal cord injury.


Listed Suppliers

read-more
read-more

01

Interquim SA

Spain
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothInterquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Flag Spain
Digital Content Digital Content

Edaravone

About the Company : Interquim, founded in 1978 and part of Ferrer HealthTech, develops high-value APIs with strict quality standards. Its facilities comply with European regulations, and products are ...

Interquim, founded in 1978 and part of Ferrer HealthTech, develops high-value APIs with strict quality standards. Its facilities comply with European regulations, and products are exported to regulated markets. Approved by regulators and clients, Interquim supports clients from development to marketing with advanced production and quality-control labs. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Interquim

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Flag U.S.A
Digital Content Digital Content

Edaravone

About the Company : ChemWerth, established in 1982, is a US-headquartered full-service generic API company. It supplies cGMP-quality APIs to regulated markets worldwide, with exclusive partnerships fo...

ChemWerth, established in 1982, is a US-headquartered full-service generic API company. It supplies cGMP-quality APIs to regulated markets worldwide, with exclusive partnerships for product development, compliance, and secure logistics. ChemWerth accesses over 500 APIs and 30 manufacturing facilities across the US, Europe, India, and China, acts as a regulatory agent for 25+ FDA-approved facilities, sells 100+ products, and operates in 38 countries. In 2020, it filed its 500th DMF with the FDA . Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Chemwerth Compnay Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Flag India
Digital Content Digital Content

Edaravone

About the Company : Biophore, founded in 2007, develops and manufactures niche and complex pharmaceutical products. With USFDA- and EU-approved API facilities, a dedicated intermediates site and an R&...

Biophore, founded in 2007, develops and manufactures niche and complex pharmaceutical products. With USFDA- and EU-approved API facilities, a dedicated intermediates site and an R&D center of 400 scientists, the company is a leading global API player. Biophore ranks among the top US DMF filers, holds 150+ patents and maintains a strong compliance record with major regulatory agencies. Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Biophore

04

LGM Pharma

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content

Edaravone

About the Company : LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product ...

LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product CDMO, offering formulation, analytical method development and testing, regulatory support, and commercial manufacturing. Supported by a network of over 220 accredited cGMP manufacturing partners and more than 100,000 sq. ft. of FDA-inspected cGMP manufacturing and warehouse space, LGM delivers secure, end-to-end solutions across multiple dosage forms. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
LGM Pharma CB

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Flag India
Digital Content Digital Content

Edaravone

About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...

Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product groups and has been approved by ISO 9001-2015, USFDA, WHO GMP, Cofepris & Japanese authorities. Metrochem’s in-depth industry knowledge, & hi-tech & advanced infrastructure, helps it provide quality products to its customers. Note: None of the products will be supplied to the countries where this could conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer
Metrochem

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

Edaravone

About the Company : Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfoli...

Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfolio that provides high-quality, low-cost APIs to leading pharma companies in 80+ countries. It has 8 USFDA-inspected facilities – 6 in India & 1 each in Mexico & the UK & are inspected by international regulatory authorities on a regular basis. Its facilities are supplemented by formulation facilities that provide a wide range of dosage forms. Product(s) under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act and not for commercial sale
Dr Reddy Company Banner

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNeuland Laboratories- A dedicated 100% API provider.

Flag India
Digital Content Digital Content

Edaravone

About the Company : Neuland Laboratories, established in 1984 and headquartered in Hyderabad, is a publicly listed company offering solutions for pharmaceutical chemistry needs—from library compound...

Neuland Laboratories, established in 1984 and headquartered in Hyderabad, is a publicly listed company offering solutions for pharmaceutical chemistry needs—from library compounds to NCEs and advanced intermediates. It manufactures APIs and intermediates in USFDA-approved facilities, applying advanced process chemistry in a regulatory-compliant environment for clinical and commercial stages. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Neuland

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSumar Biotech work together to Innovate & Manufacture Semi-synthetic, Synthetic & Fermentation API.

Flag India
Digital Content Digital Content

Edaravone

About the Company : Sumar Biotech LLP, registered in January 2018, is a startup approved by the Gujarat State Biotechnology Mission. Founded by young entrepreneurs and experienced research and manufac...

Sumar Biotech LLP, registered in January 2018, is a startup approved by the Gujarat State Biotechnology Mission. Founded by young entrepreneurs and experienced research and manufacturing professionals, the company focuses on innovating and manufacturing semi-synthetic, synthetic, and fermentation-based APIs. Its R&D facility is equipped with advanced technology for synthesis, extraction, isolation, purification, and upstream fermentation, with active work in process chemistry for therapeutic molecules. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Sumar Biotech

09

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHonour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.

Flag India
Digital Content Digital Content

Edaravone

About the Company : Honour is a leading global CDMO and trusted manufacturer of specialty chemicals and ingredients, with seven world-class facilities meeting global safety and quality standards. Thro...

Honour is a leading global CDMO and trusted manufacturer of specialty chemicals and ingredients, with seven world-class facilities meeting global safety and quality standards. Through Honour Synthesis and Honour Specialty, it delivers innovative solutions leveraging chemistry expertise. Its team of over 2,500 professionals partners with pharmaceutical, biotech, and specialty industries worldwide to develop practical, scalable solutions. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

10

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

edaravone

About the Company : CR Double-Crane Pharmaceuticals Co., Ltd (hereinafter referred to as CR Double-Crane) is a pharmaceuticals company with 75 years of brilliant history. Formerly known as Beijing Pha...

CR Double-Crane Pharmaceuticals Co., Ltd (hereinafter referred to as CR Double-Crane) is a pharmaceuticals company with 75 years of brilliant history. Formerly known as Beijing Pharmaceuticals Factory, the company was listed on Shanghai Stock Exchange in 1997 with Stock Code as 600062. In 2010, it was merged into China Resources (Group) Co, Ltd. which is one of the Global 500 companies and became the main manufacturer of chemical medicines under the Group. In 2012, the company was officially renamed from Beijing Double-Crane Pharmaceuticals Co., Ltd. to CR Double-Crane Pharmaceuticals Co., Ltd.
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

STOCK RECAP #PipelineProspector

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 89-25-8 / Edaravone API manufacturers, exporters & distributors?

Edaravone manufacturers, exporters & distributors 1

87

PharmaCompass offers a list of Edaravone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Edaravone manufacturer or Edaravone supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Edaravone manufacturer or Edaravone supplier.

API | Excipient name

Edaravone

Synonyms

89-25-8, 3-methyl-1-phenyl-2-pyrazolin-5-one, Radicut, Norphenazone, Mci-186, Developer z

Cas Number

89-25-8

About Edaravone

An antipyrine derivative that functions as a free radical scavenger and neuroprotective agent. It is used in the treatment of AMYOTROPHIC LATERAL SCLEROSIS and STROKE.

1 Phenyl 3 methyl 5 pyrazolone Manufacturers

A 1 Phenyl 3 methyl 5 pyrazolone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 1 Phenyl 3 methyl 5 pyrazolone, including repackagers and relabelers. The FDA regulates 1 Phenyl 3 methyl 5 pyrazolone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 1 Phenyl 3 methyl 5 pyrazolone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of 1 Phenyl 3 methyl 5 pyrazolone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

1 Phenyl 3 methyl 5 pyrazolone Suppliers

A 1 Phenyl 3 methyl 5 pyrazolone supplier is an individual or a company that provides 1 Phenyl 3 methyl 5 pyrazolone active pharmaceutical ingredient (API) or 1 Phenyl 3 methyl 5 pyrazolone finished formulations upon request. The 1 Phenyl 3 methyl 5 pyrazolone suppliers may include 1 Phenyl 3 methyl 5 pyrazolone API manufacturers, exporters, distributors and traders.

click here to find a list of 1 Phenyl 3 methyl 5 pyrazolone suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

1 Phenyl 3 methyl 5 pyrazolone USDMF

A 1 Phenyl 3 methyl 5 pyrazolone DMF (Drug Master File) is a document detailing the whole manufacturing process of 1 Phenyl 3 methyl 5 pyrazolone active pharmaceutical ingredient (API) in detail. Different forms of 1 Phenyl 3 methyl 5 pyrazolone DMFs exist exist since differing nations have different regulations, such as 1 Phenyl 3 methyl 5 pyrazolone USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A 1 Phenyl 3 methyl 5 pyrazolone DMF submitted to regulatory agencies in the US is known as a USDMF. 1 Phenyl 3 methyl 5 pyrazolone USDMF includes data on 1 Phenyl 3 methyl 5 pyrazolone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 1 Phenyl 3 methyl 5 pyrazolone USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of 1 Phenyl 3 methyl 5 pyrazolone suppliers with USDMF on PharmaCompass.

1 Phenyl 3 methyl 5 pyrazolone JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The 1 Phenyl 3 methyl 5 pyrazolone Drug Master File in Japan (1 Phenyl 3 methyl 5 pyrazolone JDMF) empowers 1 Phenyl 3 methyl 5 pyrazolone API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the 1 Phenyl 3 methyl 5 pyrazolone JDMF during the approval evaluation for pharmaceutical products. At the time of 1 Phenyl 3 methyl 5 pyrazolone JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of 1 Phenyl 3 methyl 5 pyrazolone suppliers with JDMF on PharmaCompass.

1 Phenyl 3 methyl 5 pyrazolone WC

A 1 Phenyl 3 methyl 5 pyrazolone written confirmation (1 Phenyl 3 methyl 5 pyrazolone WC) is an official document issued by a regulatory agency to a 1 Phenyl 3 methyl 5 pyrazolone manufacturer, verifying that the manufacturing facility of a 1 Phenyl 3 methyl 5 pyrazolone active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting 1 Phenyl 3 methyl 5 pyrazolone APIs or 1 Phenyl 3 methyl 5 pyrazolone finished pharmaceutical products to another nation, regulatory agencies frequently require a 1 Phenyl 3 methyl 5 pyrazolone WC (written confirmation) as part of the regulatory process.

click here to find a list of 1 Phenyl 3 methyl 5 pyrazolone suppliers with Written Confirmation (WC) on PharmaCompass.

1 Phenyl 3 methyl 5 pyrazolone NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 1 Phenyl 3 methyl 5 pyrazolone as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for 1 Phenyl 3 methyl 5 pyrazolone API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture 1 Phenyl 3 methyl 5 pyrazolone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain 1 Phenyl 3 methyl 5 pyrazolone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 1 Phenyl 3 methyl 5 pyrazolone NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of 1 Phenyl 3 methyl 5 pyrazolone suppliers with NDC on PharmaCompass.

1 Phenyl 3 methyl 5 pyrazolone GMP

1 Phenyl 3 methyl 5 pyrazolone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of 1 Phenyl 3 methyl 5 pyrazolone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right 1 Phenyl 3 methyl 5 pyrazolone GMP manufacturer or 1 Phenyl 3 methyl 5 pyrazolone GMP API supplier for your needs.

1 Phenyl 3 methyl 5 pyrazolone CoA

A 1 Phenyl 3 methyl 5 pyrazolone CoA (Certificate of Analysis) is a formal document that attests to 1 Phenyl 3 methyl 5 pyrazolone's compliance with 1 Phenyl 3 methyl 5 pyrazolone specifications and serves as a tool for batch-level quality control.

1 Phenyl 3 methyl 5 pyrazolone CoA mostly includes findings from lab analyses of a specific batch. For each 1 Phenyl 3 methyl 5 pyrazolone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

1 Phenyl 3 methyl 5 pyrazolone may be tested according to a variety of international standards, such as European Pharmacopoeia (1 Phenyl 3 methyl 5 pyrazolone EP), 1 Phenyl 3 methyl 5 pyrazolone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (1 Phenyl 3 methyl 5 pyrazolone USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty